ANIX: Anixa Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 87.57
Enterprise Value ($M) 85.38
Book Value ($M) 16.71
Book Value / Share 0.52
Price / Book 5.24
NCAV ($M) 16.49
NCAV / Share 0.51
Price / NCAV 5.31

Profitability (mra)
Return on Invested Capital (ROIC) -0.74
Return on Assets (ROA) -0.49
Return on Equity (ROE) -0.53

Liquidity (mrq)
Quick Ratio 9.35
Current Ratio 9.35

Balance Sheet (mrq) ($M)
Current Assets 18.69
Assets 18.91
Liabilities 2.19
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -13.83
Net Income -12.55
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -7.33
Cash from Investing 4.28
Cash from Financing 3.42

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
01-03 13D/A Kumar Amit 15.10 15.74
05-03 13D Catelani Michael 5.25

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-01-10 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-09-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-06-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 3,431 18,150 18.90
2025-04-16 7,529 13,842 54.39
2025-04-15 22,794 68,104 33.47

(click for more detail)

Similar Companies
ALTS – JanOne Inc. ALZN – Alzamend Neuro, Inc.
ANEB – Anebulo Pharmaceuticals, Inc. APM – Aptorum Group Limited
APRE – Aprea Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.